This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
KMI.WS ECOR PLNT KMI.PRA PKG AEP NINE ADT GE COF-P GILD TMUS PDYPF SYF XERS JNJ VZ MSFT ADS KZR NNN EIDX FB RF.PRB AVRO RF.PRA HOPE NFLX AXP EHC BAC COF-D SEAS COF-C COF-F KR KS IIIV PNFP AAPL DDOC AEP.PRA SJM INPAP SIX JPM GNE WRK LGEJY KMRFZ DE 39IB KMX COF.WS RF UAL WMT CFIN LGEAF IP AMZN MGTA NTRS HON KMI CIWV GM.WS.A GM.WS.B HCSG GM.WS.C KMR CVB VLKAY LGEIY EBAY EPRT STT SLB BAC DFS LGEPF STM BBY BX BK STM LTXB LGLD SLB GM.WSB FOXA CLW COF.PRG COF.PRH PM STT.PRC STT.PRE NTRSP STT.PRD STT.PRG AUTL COF.PRP DLPH SWKS GS SWK TRTX GM PII COF.PRC COF.PRD DIS NEE COF.PRF IBM MOR F GEC C CMCSA COF FUN FUL CFG HBAN NEE.PRI XEL NEE.PRJ TGT BLK S PPG T NEE.PRC NEE.PRQ NEE.PRR SNE DPZ
Delphi Technologies PLC (DLPH - Free Report) looks strong on the back of its vast global network and innovative product portfolio with updated technologies. The aftermarket business generates stable recurring revenues.
BCOR APTV IQV DLPH
Global oil prices rose on Tuesday as concerns related to supply levels continue to mount. A strike in Norway and disruptions in Libya have added to these concerns, while sanctions against Iran and the ongoing Venezuela crisis have devastated inventory. Nevertheless, disciplined oil behemoths like BP plc (BP - Free Report) might actually be able to take advantage of these trends.
Delphi Technologies PLC (DLPH - Free Report) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at DLPH given that, according to its RSI reading of 25.33, it is now in oversold territory.
The futures were again trading higher Monday morning. Despite concerns over the recently imposed tariffs around the world, investors and Wall Street have their attention focused on second-quarter earnings results, which will begin this week. The trend of buying the dips has not worked as well as it has in prior years, and many investors have been considering how they want their investments positioned for the longer term.
COF.PRG COF.PRH COF.WS MS.PRE COF.PRP MS.PRF MS.PRG MS.PRA DLPH COF-D COF-C COF-F FEYE MS COF.PRC BIDU COF.PRD HSY COF.PRF HSYFB COF-P COF MS.PRI BJ MS.PRK DNKN TRI
CVR Refining (CVRR - Free Report) , a Zacks Ranked #1 (Strong Buy) is engaged in the refining of petroleum primarily in the United States. It has refining and related logistics assets that operate in the mid-continent region. The company operates in Coffeyville, Kansas, Wynnewood and Oklahoma. CVR Refining, LP is headquartered in Sugar Land, Texas.
Based in San Francisco, CA, Zendesk Inc. (ZEN - Free Report) is a software development company that provides a software-as-a-service (SAAS) customer service platform. With its various applications, clients get to manage incoming support requests from end customers in many different industries, from business technology, telecommunications, and education/non-profit to consumer technology, media/entertainment, and retail & e-commerce.
ZEN PII DLPH
Chicago, IL – July 5, 2018 – Zacks Equity Research highlights Delphi Technologies PLC (DLPH - Free Report) as the Bull of the Day and Deutsche Bank (DB - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Walmart (WMT - Free Report) and Amazon (AMZN - Free Report) .
DB 6755 FGELF STX SMCI WMT DLPH
Chicago, IL –July 5, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Pfizer (PFE - Free Report) , BHP Billiton (BHP - Free Report) , Facebook (FB - Free Report) , Tesla (TSLA - Free Report) and Humana (HUM - Free Report) .
FB DB BLT ABX BHPBF DVN HUM JOUT DLPH BHP BSX AMCX GM.WS.A GM.WS.B GM.WS.C BBL BHP GM GM.WSB BHPLF PFE ABX
After struggling for the first five months in 2018, the biotech industry started to recover since the end of May. The industry, which was down 8.9% in first five months, rose 1.8% in June compared with an increase of 0.7% registered by the broader S&P 500.
DB FCSC ATNX RYTM DLPH
The construction sector tumbled in the first half thanks to higher material costs and a rising rate environment, which pushed up interest/mortgage rates. If this wasn't enough, Trump’s steel and aluminum import tariffs have raised further apprehensions. Much like the broader market that is also battling volatility this year, the housing industry is now in a bear territory, with a loss of 19.7% through the first six months.
In the last five trading days, telecom stocks witnessed a sharp rise initially as China eased some foreign investment curbs but fell slightly thereafter to maintain a flat trajectory. The stocks regained the lost ground later in the week due to temporary relief to ZTE to resume some business activities. Amid the looming trade war tensions between the United States and China, the communist nation took a positive step toward easing the limits on foreign ownership in some of its closely guarded sectors.
HCOM DB CHLKF DLPH VZA T 0941 MSI CBB CHL VZ QCOM SBAC CBB.PRB TU
A layman can end up losing bucks if he decides to pick a stock only on the basis of numbers flashing on a real-time stock screen. A critical analysis of a company’s financial background is essential for a better investment decision.
INTU DB BOE WCG BA LAD DIS DLPH
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to DLPH / Delphi Technologies PLC on message board site Silicon Investor.
|DLPH...Delphi Information Systems|
as of ET